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Human mitochondrial translational initiation factor 3
(IF3mt) has been identified from the human expressed
sequence tag data base. Using consensus sequences de-
rived from conserved regions of the bacterial IF3, sev-
eral partially sequenced cDNA clones were identified,
and the complete sequence was assembled in silico from
overlapping clones. IF3mt is 278 amino acid residues in
length. MitoProt II predicts a 97% probability that this
protein will be localized in mitochondria and further
predicts that the mature protein will be 247 residues in
length. The cDNA for the predicted mature form of IF3mt
was cloned, and the protein was expressed in Esche-
richia coli in a His-tagged form. The mature form of
IF3mt has short extensions on the N and C termini sur-
rounding a region homologous to bacterial IF3. The re-
gion of IF3mt homologous to prokaryotic factors ranges
between 21–26% identical to the bacterial proteins. Pu-
rified IF3mt promotes initiation complex formation on
mitochondrial 55 S ribosomes in the presence of mito-
chondrial initiation factor 2 (IF2mt), [
35S]fMet-tRNA, and
either poly(A,U,G) or an in vitro transcript of the cyto-
chrome oxidase subunit II gene as mRNA. IF3mt shifts
the equilibrium between the 55 S mitochondrial ribo-
some and its subunits toward subunit dissociation. In
addition, the ability of E. coli initiation factor 1 to stim-
ulate initiation complex formation on E. coli 70 S and
mitochondrial 55 S ribosomes was investigated in the
presence of IF2mt and IF3mt.
Mammalian mitochondria synthesize 13 polypeptides that
are essential for oxidative phosphorylation. These 13 proteins
are translated from nine monocistronic and two dicistronic
mRNAs with overlapping reading frames (1, 2). The protein-
synthesizing system of mammalian mitochondria has a num-
ber of interesting features not observed in prokaryotes or the
cell cytoplasm (3). The mRNAs in this organelle have an almost
complete lack of 5- and 3-untranslated nucleotides. The start
codon is generally located within three nucleotides of the 5 end
of the mRNA (1, 4). Thus, mammalian mitochondrial ribosomes
do not recognize the start codon using the Shine/Dalgarno
interaction between the mRNA and the 16 S rRNA as observed
in prokaryotes. Further, this system does not use a cap-binding
and scanning mechanism such as observed in the eukaryotic
cytoplasm.
Three translational initiation factors, IF1, IF2, and IF3,1 are
required for the initiation of protein synthesis in bacteria (5–7).
Prior to the present report, the homolog of only one of these
factors, IF2mt, had been identified, cloned, and characterized in
mammalian mitochondria (8–12). Similar to its prokaryotic
counterpart, IF2mt promotes the binding of fMet-tRNA to the
small subunit of mitochondrial ribosomes in response to syn-
thetic polynucleotides such as poly(A,U,G).
The current report describes the identification and initial
characterization of the mammalian mitochondrial factor equiv-
alent to IF3. In prokaryotes IF3 has a number of roles in the
initiation of protein synthesis. IF3 binds to the 30 S subunit
and inhibits its association with the 50 S subunit, thus ensur-
ing a supply of 30 S subunits for initiation (13, 14). IF3 also
promotes an adjustment of the position of the mRNA on the 30
S subunit facilitating codon-anticodon interactions between the
AUG codon and fMet-tRNA in the P site (15–18). IF3 acts to
switch the decoding preference of the small ribosomal subunit
from elongator tRNAs to the initiator tRNA in the P site, thus
playing a proofreading role in initiation (19–21). IF3 is a small
protein of 180 amino acids that folds into two distinct domains
separated by a long flexible linker. The C-terminal domain is
thought to carry out most of the direct functions of this factor,
whereas the N-terminal domain stabilizes the interaction of
IF3 with the 30 S subunit (22).
No factor equivalent to IF1 has been observed in the mito-
chondria from any system nor can an EST for this protein be
identified in the human EST data bases. A gene for IF1 is,
however, apparent in many chloroplast genomes. This small
protein (less than 90 residues) binds to the 30 S subunit around
helix 44 in the region that will become the A site (23). By
binding to this site, IF1 is postulated to prevent accidental
initiation from the A site and to promote the correct positioning
of fMet-tRNA in the P site (24, 25). In the current report, IF3mt
has been identified and characterized, and the effects of bacte-
rial IF1 on the function of IF2mt and IF3mt have been
investigated.
MATERIALS AND METHODS
Preparation of Ribosomes and Initiation Factors—Bovine mitochon-
dria and 55 S ribosomes were prepared as described previously (26).
Escherichia coli ribosomes were prepared as described (27, 28), and
tight couples were collected from a sucrose gradient in the presence of
5 mM Mg2 (29). Bovine IF2mt, yeast [
35S]fMet-tRNA, and E. coli initi-
ation factors were prepared as described (12, 28). E. coli IF2 was also
prepared from an expression construct providing a mixture of the  and
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FIG. 1. Sequence and domain organization of IF3mt. A, domain organization of prokaryotic and mitochondrial IF3. B, amino acid sequence
of human IF3mt and alignment with its prokaryotic homologs from B. stearothermophilus (B.st) and E. coli. The predicted site of cleavage following
import into mitochondria is indicated by the arrow (3). The location of the proteolytic cleavage observed in a portion of the factor during expression
in E. coli is indicated by the arrow (1). The asterisks indicate residues implicated in the binding of bacterial IF3 to 30 S subunits. C, alignment
of the amino acid sequence of human IF3mt with its homologs from Bos taurus (Bovine), Mus musculus (Mouse), F. rubripes (Fugu), and D.
melanogaster (Drosophila). The alignment was done with the CLUSTALW program in Biology Workbench, and the results are displayed in
BOXSHADE. The full sequence of the F. rubripes IF3mt is not shown for convenience. D, alignment of human IF3mt with the putative IF3mt from
S. pombe.
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 forms of IF2 (kindly provided by Angela Coursey, University of North
Carolina). The genes for E. coli IF3 and IF1 (kindly provided by Drs.
Roberto Spurio and Claudio Gualerzi, University of Camerino, Italy,
and Dr. Rebecca Alexander, Wake Forest University, respectively) were
also amplified by PCR and cloned into pET-21(c). The constructs car-
rying E. coli IF3 and IF1 were transformed into an E. coli BL21(DE3)
strain that also carried the plasmid pArgU218 (kindly provided by Dr.
Yamada, Mitsubishi Chemical Corp., Yokohama, Japan). The His-
tagged forms of the E. coli initiation factors were purified on Ni-NTA
resins as described below.
Cyberprobing for Mitochondrial Translational Initiation Factor
3—EST and genomic data base searches for human IF3mt were per-
formed using BLAST (National Center for Biotechnology Information)
and the sequences of various prokaryotic IF3s as virtual probes (30).
Sequence analysis was done using the GCG DNA analysis software
package (Wisconsin Package, version 10, Genetics Computer Group,
Madison WI), Vector NTI (Informax Inc.), and Biology WorkBench 3.2.
The results were displayed using BOXSHADE (written by K. Hofmann
and M. Baron). Prediction of the cleavage sites for the mitochondrial
signal sequence was carried out using PSort and MitoProt II (31, 32).
Protein secondary and tertiary structures were predicted using Inter-
net-based software, PHDsec and SWISS-Model, respectively (33, 34).
Cloning of Human IF3mt into an Expression Vector—A full-length
cDNA clone in vector pT7T3D-Pac carrying the human mitochondrial
IF3mt cDNA was obtained from the American Culture Type Collection
(number 526483). The region predicted to be present in the mature form
of human IF3mt (residues 32–278) was amplified by PCR using the
full-length cDNA as a template. The portion of the IF3mt cDNA pre-
dicted to correspond to the mature protein was cloned between the NdeI
and XhoI sites of pET-21(c) using the forward primer 5-CGCGGATC-
CAATTCATATGGCTGCTTTTTCT-3 and the reverse primer 5-
CGCGGATCCGCTCGAGCTGATGCAGAACAT-3. This vector pro-
vides a His tag at the C terminus. The construct carrying the human
IF3mt was transformed into E. coli BL21(DE3) carrying the plasmid
pArgU218 (Dr. Yamada, Mitsubishi Chemical Corp., Yokohama, Ja-
pan), which provides the gene for the isoacceptor of tRNAArg recognizing
the AGA and AGG codons.
Expression and Purification of IF3mt—Induction of IF3mt with 50 M
isopropylthiogalactoside was carried out for 5 h at 37 °C after the cell
density had reached 0.5 at OD600. The cells were harvested by low speed
centrifugation, and IF3mt was purified through a Ni-NTA column as
described (35). Protein concentrations were determined by the Micro-
Bradford method (Bio-Rad). Because of the presence of the 19-kDa form
of IF3mt found in the Ni-NTA column preparations, a second step of
purification was carried out using high performance liquid chromatog-
raphy. In this procedure, the partially purified IF3mt preparation pre-
pared from 2 liters of cell culture (2 mg/ml, 6 mg) was dialyzed against
100-fold excess of Buffer A (20 mM HEPES-KOH, pH 7.6, 10 mM Mg2Cl,
6 mM -mercaptoethanol, 225 mM KCl, and 10% glycerol) for 1.5 h. The
dialyzed sample was applied at a flow rate of 0.5 ml/min to a TSKgel
SP-5PW column (7.5  75 mm, TosoHas Inc., Japan) that had been
equilibrated in Buffer A except that the KCl was adjusted to 240 mM.
The column was washed until the absorbance at 280 nm returned to
base line. The column was then developed with a linear gradient (50 ml)
from 0.24 to 0.30 M KCl in Buffer A at a flow rate of 0.5 ml/min. The
fractions (0.5 ml) were collected. The fractions containing IF3mt and its
major degradation product were pooled separately and fast-frozen in a
dry ice isopropyl alcohol bath and stored at 70 °C. The N-terminal
sequences of the expressed forms of IF3mt were determined using a
Perkin Elmer/ABI Procise model 492 protein/peptide sequencer.
Preparation of mRNA Transcripts—The previously described clone
carrying the bovine cytochrome oxidase subunit II (CoII) gene (36) was
modified to provide a sequence of 30 A residues at the 3 end. The
transcript prepared from this vector mimics mitochondrial mRNAs
produced in vivo, which generally have poly(A) stretches up to 70
residues added following transcription and processing (37). In vitro
transcripts were prepared as described previously (36).
Initiation Complex Formation Assays—The activity of IF3mt in pro-
moting initiation complex formation with E. coli and mitochondrial
ribosomes was assayed using conditions basically described previously
(8, 9). Reaction mixtures (100 l) contained 0.5 OD260 units of E. coli 70
S or 0.075–0.15 OD260 units of mitochondrial 55 S tight couples, 12.5 g
of poly(A,U,G), or 10 pmol of the CoII mRNA, 3.8 pmol of [35S]fMet-
tRNA, and the indicated amounts of various initiation factors. All of the
initiation complex formation assays were incubated at 37 °C for 15 min
and analyzed as described (8).
Dissociation of Mitochondrial 55 S Ribosomes by IF3mt—The reaction
mixtures (100 l) were prepared containing 25 mM Tris-HCl, pH 7.6, 2
mM Mg2, 100 mM KCl, 0.5 mM EDTA, 1 mM dithiothreitol, 5% glycerol,
0.2 OD260 units of 55 S ribosomes, and variable amounts of IF3mt
(0–1.72 g). The reactions were incubated for 15 min at 37 °C. The
Mg2 concentration was then adjusted to 7 mM by the addition of 2.5 l
of 0.1 M MgCl2, and the samples were analyzed for 28, 39, and 55 S
particles on 10–30% (w/v) linear sucrose gradients prepared in the
buffer described above containing 7 mM Mg2 and analyzed as described
previously (38).
RESULTS AND DISCUSSION
Identification of the cDNA for IF3mt and Analysis of the
Coding Region—Although the mammalian mitochondrial ribo-
some has a low percentage of rRNA and a high protein content
compared with bacterial ribosomes, portions of the rRNA
where IF3 is thought to bind are present (39). Further, the
ribosomal proteins with which IF3 interacts (S7, S11, and S18)
have homologs in the 28 S subunit. Hence, it was logical to
postulate that mammalian mitochondria contain a homolog of
bacterial IF3. Probing the human ESTs with the amino acid
sequence of E. coli or most other IF3 species fails to provide any
convincing evidence for a mammalian mitochondrial homolog
of IF3. However, extensive data base searches with the se-
quences of IF3 from the Mycoplasma and the IF3 homology
domain of Euglena gracilis chloroplast IF3 provide a hit in both
the human and mouse EST data bases. The sequence detected
FIG. 1—continued
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by this search encodes a 278-amino acid protein (Fig. 1A).
MitoProt II gives this protein a 97% probability to be localized
in mitochondria and predicts that the mature protein will be
247 residues in length. The mature form of IF3mt is predicted to
have an N-terminal extension of about 30 residues (Fig. 1, A
and B) that can form a coiled region followed by an -helix. An
N-terminal extension of about 150 residues has been noted on
E. gracilis chloroplast IF3 (IF3chl) (40). IF3mt also has a C-
terminal extension just over 30 residues long. Overall, it is
quite hydrophilic and highly charged having nine acidic and
five basic residues. The C-terminal extension, like the N-ter-
minal extension, is predicted to have significant helical con-
tent. A 63-residue acidic C-terminal extension on E. gracilis
IF3chl has been shown to reduce the activity on the chloroplast
factor in initiation complex formation and may serve as a
potential regulatory region (41).
Alignment of IF3mt with prokaryotic and chloroplast IF3
indicates that the mitochondrial factor has diverged consider-
ably from other IF3s (Table I). Overall, it has only 20.8%
identity to E. coli IF3, which explains the failure of data base
searches with the sequence of E. coli IF3 to locate the corre-
sponding mitochondrial factor. IF3mt is 25.9% and 23.7% iden-
tical to Bacillus stearothermophilus IF3 and to E. gracilis chlo-
roplast IF3, respectively (40). Alignment of the sequence of
IF3mt with the bacterial factors indicates that regions of iden-
tity are rather scattered throughout the structure (Fig. 1B).
Residues that are responsible for the binding of IF3 to the small
subunit are thought to be located primarily in the C-terminal
domain. Crystallography experiments place the C-terminal do-
main of IF3 on the solvent side of the platform on the 30 S
subunit (42), whereas cryo electron microscopy and footprinting
suggest that it is located on the interface side (39, 43). Important
regions of IF3 include residues 99–116, 127–137, 145–155, and
168 (E. coli numbering) as indicated by NMR experiments, mu-
tagenesis, and structural studies (39, 42, 44). A number of the
residues in these regions are conserved or are conservative re-
placements in the C-terminal domain of human IF3mt.
One of the major roles of prokaryotic IF3 is the discrimina-
tion of the initiation codon (AUG or occasionally GUG or UUG)
from other codons. This property can be observed in the iso-
lated C-terminal domain of bacterial IF3 (22) but is strongly
affected by conserved residues in the linker region (17, 45, 46).
Interestingly, these highly conserved residues, Tyr70, Gly71,
and Tyr75, in prokaryotic IF3s are not conserved in human
IF3mt. In mammalian mitochondria, both AUG and AUA (nor-
mally an isoleucine codon) serve as initiation codons. Conse-
quently, the proofreading properties of human IF3mt could be
quite different from those of the bacterial factors.
Analysis of the mouse and bovine EST data bases indicates
the presence of mammalian homologs of human IF3mt that are
65–70% identical to the human factor (Table I and Fig. 1C). In
addition, BLAST searches indicate the presence of IF3mt in
Fugu rubripes (puffer fish) and in Drosophila melanogaster
(Table I and Fig. 1C). No homolog can be detected in Caeno-
rhabditis elegans. It is quite reasonable to assume that this
organism will have a corresponding factor. However, IF3mt
does not appear to be highly conserved throughout the animal
kingdom, and it may be difficult to detect using BLAST
searches.
The IF3mt species detected in animals generally have N- and
C-terminal extensions that surround a central section that has
homology to the bacterial IF3s. The N-terminal extension on
puffer fish IF3mt is considerably longer than that observed on
FIG. 2. Three-dimensional models of human IF3mt based on the
crystal structures of the N- and C-terminal domains of B. stearo-
thermophilus IF3. A, N domain of B. stearothermophilus IF3 taken
from the Protein Data Bank (accession number 1TIF) and displayed
using RasMol (51). B, model of the N domain of IF3mt generated using
Swiss-Model and the coordinates from the N domain of B. stearother-
mophilus IF3. The site of cleavage generating the 19-kDa fragment of
IF3mt observed in the factor expressed in E. coli is indicated by the
arrow. The linker region could not be modeled because of the low degree
of homology observed between the bacterial and mitochondrial proteins
in this region of the sequence. C, C domain of B. stearothermophilus IF3
taken from the Protein Data Bank (accession number 1TIG). D, partial
model of the C-terminal domain of IF3mt generated using Swiss-Model
and the coordinates of B. stearothermophilus IF3. Only a portion of this
domain could be modeled because of the low degree of sequence conser-
vation. The helical regions are indicated as H1–H4.
TABLE I
Percentage of identity of human mitochondrial IF3 homologs
The percentage identity between human IF3mt and the bacterial factors is reported for the homology region only.
Organism Identity Length Accession number
%
B. stearothermophilus 25.9 172 P03000
Mycoplasma genitalium 24.6 184 P47438
Mycoplasma pneumoniae 21.5 201 NP_109803
E. coli 20.8 180 P02999
E. gracilis (chloroplast) 23.7 538 L23760
A. thaialana (chloroplast) 24.4 312 NP_179984
S. pombea 20.9 233 T39948
S. cerevisiaea 16.2 370 NP_011356
B. taurus (mitochondrial) 69.5 273 cDNAsb
Mouse (mitochondrial) 66.0 276 BAB28438
Drosophila (mitochondrial) 22.6 226 AAF58534
F. rubripes (mitochondrial) 30.9 362 JGI_17846
a Putative mitochondrial initiation factor 3.
b cDNA sequences encoding for bovine IF3mt: AW658739 (nucleotides 316–582, aa residues 1–89), AW445348 (nucleotides 1–408, aa residues
26–161), BM106922 (nucleotides 270–112, aa residues 149–201), and BM255983 (nucleotides 79–360, aa residues 180–273).
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the mammalian factors (Fig. 1C). D. melanogaster IF3mt has a
very short N-terminal extension. The mammalian and puffer
fish IF3mts all have C-terminal extensions of around 30 resi-
dues compared with the bacterial IF3s. However, D. melano-
gaster IF3mt again lacks a significant extension at the C ter-
minus. The linker regions of the mitochondrial factors are
charged as observed for the prokaryotic proteins.
Two potential homologs of IF3mt can be found in Arabidopsis
thaliana. One of these genes probably encodes the chloroplast
factor, whereas the other encodes the mitochondrial factor.
These two forms (NP-179984 and NP-174696) differ consider-
ably in length (312 and 574 residues, respectively). Alignments
of these two species with E. gracilis chloroplast IF3 suggests
that the shorter form is more likely to encode the chloroplast
factor based on the percentage of identity. However, the shorter
form also has a higher percentage of identity to human IF3mt
than the longer form, making it difficult to assign these two
species clearly to one or the other compartments.
Cyberprobing of the recently completed genome of Schizo-
saccharomyces pombe allows the tentative identification of
IF3mt in this organism (47). The protein encoded by this gene is
20.9% identical to human IF3mt and 25% identical to E. coli IF3
(Table I and Fig. 1D). If the predicted import signal is cleaved
from S. pombe IF3mt, no N-terminal extension would be pres-
ent. IF3mt from S. pombe does not have any observable
C-terminal extension. Searching the genome of Saccharomyces
cerevisiae with the sequence of human IF3mt fails to indicate
the presence of a yeast homolog. However, a possible candidate
can be detected that is 23.9% identical to the S. pombe factor
over the IF3 region. The S. cerevisiae protein is considerably
longer than traditional IF3s, and its classification as a mito-
chondrial IF3 remains to be clarified.
Development of Three-dimensional Models for the N and C
Domains of IF3mt—The coordinates for the crystal structures of
N and C domains of B. stearothermophilus IF3 were used to
model the N and C domains of human IF3mt using Swiss-
Model. The N-terminal domain of IF3 has a globular / topol-
ogy consisting of a single -helix packed against a four-
stranded -sheet (Fig. 2A). This domain leads into the
connecting linker, which is helical in the crystal structure but
is quite flexible in solution (48). As indicated in Fig. 2B, the
N-terminal domain of IF3mt is predicted to fold into a highly
similar structure. The linker region is not shown in this model.
The C-terminal domain of bacterial IF3 also consists of an
/ fold with two helices packed against a four-stranded sheet
(Fig. 2C). The C-terminal domain of IF3mt could not be fully
modeled because of low sequence conservation and the unclear
alignment of portions of the molecules (Fig. 2, C and D). How-
ever, the first -helix and the first two strands of the -sheet
can be modeled to resemble the prokaryotic factors quite well.
It is likely that the remainder of the C-terminal domain will
have a similar overall fold to that observed in prokaryotic IF3
despite the low sequence conservation.
The linker region separating the N and C domains of IF3 is
a rigid helix in the crystal structure of B. stearothermophilus
IF3 but is more flexible in the NMR structure of E. coli IF3
(48–52). Structural studies suggest that the linker must be
flexible to allow IF3 to interact with distant regions of the small
FIG. 3. Purification of human IF3mt after expression in E. coli. A, SDS-PAGE analysis of the IF3mt fractions after each purification step.
Lane 1, molecular mass markers with their sizes indicated in kDa. Lane 2, Ni-NTA column purified IF3mt (25 g). Lane 3, TSKgel SP-5PW column
purified IF3mt (5 g). The gel was stained with Coomassie Brilliant Blue. B, elution profile of IF3mt from the TSKgel SP-5PW column showing the
separation of intact IF3mt and the 19-kDa proteolytic fragment.
FIG. 4. Effects of IF3mt on the disso-
ciation of mitochondrial ribosomal
subunits. A, mitochondrial 55 S ribo-
somes (0.2 OD260) were incubated as de-
scribed under “Materials and Methods” at
2 mM Mg2 in the absence of added IF3mt,
then the Mg2 concentration was subse-
quently raised to 7 mM, and the mixture
was analyzed for monosomes and sub-
units by sucrose density gradient centrif-
ugation as described previously (38). B,
mitochondrial ribosomes (0.2 OD260, 6
pmol) were incubated at 2 mM Mg2 in the
presence of 1.72 g of IF3mt. The Mg
2
concentration was subsequently raised to
7 mM, and the mixture analyzed for mono-
somes and subunits by sucrose density
gradient centrifugation.
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subunit (39, 42, 43). Secondary structure predictions on the
linker region of IF3mt indicate that it could form a helical
conformation, particularly as it exits the N-terminal domain.
However, the linker in IF3mt contains two proline residues
near its junction with the C-terminal domain. Proline residues
are not observed in the linker regions of prokaryotic IF3s.
These residues would be expected to reduce the flexibility of the
linker and may help confer a specific orientation between the
N- and C-terminal domains in the mitochondrial factor. Both
proline residues are conserved in the mammalian factors,
whereas the second is also seen in puffer fish IF3mt.
Purification of Overexpressed IF3mt—The portion of the
cDNA for human IF3mt corresponding to the region predicted to
be present in the mature form of the protein (amino acids
32–278) was cloned into an expression vector providing a His
tag. When the mature form of IF3mt was expressed, two major
bands of protein were observed on SDS-PAGE following puri-
fication on Ni-NTA resins (Fig. 3A, lane 2). The highest molec-
ular mass form migrated at 29 kDa, the size expected for the
mature form of this factor. A second shorter form of IF3mt
migrated at 19 kDa (Fig. 3A). Both of these bands cross-reacted
with the antibody prepared against E. gracilis IF3chl on West-
erns (data not shown). These two forms of IF3mt were purified
by high performance liquid chromatography (Fig. 3). N-termi-
nal analysis of the 29-kDa form showed that it begins with the
sequence TAP, indicating that it was expressed from the start
site predicted for the mature form of the protein following
removal of the initiating Met. N-terminal sequencing of the
19-kDa species gave the sequence GNMHRAN, indicating that
it arose from the proteolytic degradation of IF3mt at amino acid
97 (arrows in Figs. 1B and 2B), which is located in the helical
segment in the middle of the N-terminal domain of IF3mt.
Effect of IF3mt on the Equilibrium between the 55 S Ribosome
and Its Subunits—Bacterial IF3 acts as a ribosome dissociation
factor. The ability of IF3mt to affect the equilibrium between
the mitochondrial 55 S ribosome and its 28 and 39 S subunits
was examined in a two-step assay. In the first step, IF3mt was
incubated with mitochondrial ribosomes at 2 mM Mg2. At this
concentration of Mg2, a significant fraction of the 55 S ribo-
somes dissociates into subunits giving IF3mt access to 28 S
subunits (38). In the second stage, the Mg2 concentration was
raised to 7 mM, promoting the reassociation of the subunits.
FIG. 5. Activity of IF3mt on mitochondrial 55 S ribosomes and on E. coli 70 S ribosomes. A, fMet-tRNA binding to mitochondrial 55 S
particles was examined in the presence of the indicated amounts of either E. coli IF3 or IF3mt and in the presence of a saturating amount of IF2mt.
A blank representing the amount of label retained on the filter in the absence of IF3 (0.1 pmol) has been subtracted from each value. B, stimulation
of fMet-tRNA binding to 70 S ribosomes with the indicated amount of either E. coli IF3 or IF3mt and in the presence of a saturating amount of E.
coli IF2 and E. coli IF1. A blank representing the amount of label retained on the filter in the absence of IF2 (about 0.3 pmol) has been subtracted
from each value. C, fMet-tRNA binding to 70 S ribosomes in the presence of either E. coli IF3 or IF3mt with a saturating amount of IF2mt. A blank
representing the amount of label retained on the filter in the absence of IF3 (about 0.9 pmol) has been subtracted from each value. For unknown
reasons, background values in the presence of IF2mt are higher than those observed in the presence of the other initiation factors. The E. coli IF3
and IF3mt are shown with (E) and (), respectively.
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Binding of IF3mt to the 28 S subunits in the first step would be
expected to result in an increased amount of ribosomal sub-
units following the increase in the Mg2 concentration. The
distribution of ribosomal particles was monitored by sucrose
density gradient centrifugation. The significant fraction of the
mitochondrial ribosomes were present as 55 S particles follow-
ing the increase in the Mg2 concentration to 7 mM (Fig. 4A).
However, in the presence of IF3mt, a substantial increase in the
presence of 28 and 39 S subunits was observed (Fig. 4B). This
observation demonstrates that IF3mt acts as a subunit anti-
association factor in mammalian mitochondria as it does in
bacteria.
Activity of IF3mt in Initiation Complex Formation and Ribo-
some Specificity—The ability of IF3mt to promote initiation
complex formation on mitochondrial ribosomes was examined
by testing its effect on fMet-tRNA binding to ribosomes in the
presence of IF2mt and poly(A,U,G). As indicated in Fig. 5A, the
presence of IF3mt increased the amount of fMet-tRNA binding
observed. This result is expected based on the ability of IF3mt to
increase the availability of 28 S subunits required for the
activity of IF2mt. IF3mt did not stimulate binding of fMet-tRNA
to 28 S subunits, suggesting that its effect in the initiation
FIG. 6. Stimulation of fMet-tRNA binding to 55 S ribosomes by
IF3mt in the presence of an in vitro transcript of the cytochrome
oxidase subunit II gene (CoII mRNA) or poly(A,U,G) as a syn-
thetic mRNA. The reaction mixtures were prepared as described un-
der “Materials and Methods” and contained the indicated amount of
IF3mt and a saturating amount of IF2mt. A blank representing the
amount of label retained on the filter in the absence of IF3 (less than 0.1
pmol) has been subtracted from each value.
FIG. 7. Effects of E. coli IF1 on fMet-tRNA binding to 55 and 70 S ribosomes. A, initiation complex formation was monitored on
mitochondrial 55 S ribosomes. The reaction mixtures were prepared as described under “Materials and Methods” and contained the indicated
amount of IF3mt, a saturating amount of IF2mt, and either 0.14 g of over-expressed and purified E. coli IF1 () or a compensating amount of buffer
(). A blank representing the amount of label retained on the filter in the absence of IF3 (0.15 pmol) has been subtracted from each value. B,
fMet-tRNA binding to E. coli 70 S ribosomes was examined in the presence of a limiting amount of E. coli IF2 in the presence () or absence ()
of 0.7 g of E. coli IF1 and in the presence of a saturating amount (50 pmol) of E. coli IF3. A blank representing the amount of label retained on
the filter in the absence of IF2 (0.25 pmol) has been subtracted from each value. C, fMet-tRNA binding to E. coli 70 S ribosomes was examined in
the presence of a limiting amount of IF2mt in the presence () or absence () of 0.7 g of E. coli IF1 and in the presence of a saturating amount
(50 pmol) E. coli IF3. A blank representing the amount of label retained on the filter in the absence of IF2mt (0.19 pmol) has been subtracted from
each value. D, initiation complex formation on 70 S ribosomes in the presence of a saturating amount of IF2mt (2.2 pmol) and the indicated amounts
of IF3mt and in the presence () and absence () of 0.7 g of native E. coli IF1. A blank representing the amount of label retained on the filter in
the absence of IF3mt but in the presence of IF2mt (0.7 pmol) has been subtracted from each value.
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assay arises primarily from its ability to promote the dissocia-
tion of ribosomes.
Previously, it has been shown that E. coli IF3 promotes the
dissociation of mitochondrial ribosomes into 28 and 39 S sub-
units (38, 53). This observation suggests that it might be active
in promoting initiation complex formation on mitochondrial
ribosomes. As indicated in Fig. 5A, E. coli IF3 also promotes
initiation complex formation on mitochondrial 55 S ribosomes
as expected from its activity as a ribosome dissociation factor.
In contrast to the activity on E. coli IF3 on mitochondrial
ribosomes, E. coli IF2 is not active on 55 S ribosomes (9).
The activity of IF3mt on E. coli 70 S ribosomes was tested by
examining its ability to promote the binding of fMet-tRNA to
these ribosomes in the presence of E. coli IF2 (Fig. 5B). Some-
what surprisingly, IF3mt showed no activity on the bacterial
ribosomes under these conditions. This observation is in con-
trast to the activity of IF2mt which is quite active on 70 S
ribosomes (8). Two possible explanations can be put forward to
explain this observation. First, it is possible that IF3mt cannot
bind to bacterial ribosomes. Second, IF3mt might bind to bac-
terial small subunits but not permit the binding of E. coli IF2,
which would be required for fMet-tRNA binding. To distinguish
between these two possibilities, fMet-tRNA binding assays to
70 S ribosomes were carried out using bovine IF2mt, which is
active on bacterial ribosomes. As indicated in Fig. 5C, under
these conditions, IF3mt is quite active in promoting fMet-tRNA
binding to E. coli ribosomes. This observation indicates that
IF3mt can bind bacterial ribosomes but that its presence is
incompatible with the activity of E. coli IF2. Examination of the
structures of E. coli and mitochondrial IF2 indicates that the
mitochondrial factor is significantly shorter than E. coli IF2.
Indeed, IF2mt lacks both domains I and II in the six-domain
model of E. coli IF2 (12, 54). Domain II has been implicated in
the binding of E. coli IF2 to 30 S subunits (55). The absence of
this domain in IF2mt may allow both IF3mt and IF2mt to bind to
the small subunit at the same time.
Stimulation of Initiation Complex Formation in the Presence
of Natural mRNAs by IF3mt—It has not yet been possible to
assemble an initiation complex using a “natural” mRNA in the
mammalian mitochondrial system. To further test the effect of
IF3mt on fMet-tRNA binding in initiation, its activity was ex-
amined in the presence of an in vitro transcript of the cyto-
chrome oxidase subunit II gene (CoII mRNA). As indicated in
Fig. 6, IF3mt stimulated fMet-tRNA binding with CoII mRNA
on 55 S ribosomes. As mentioned earlier, mitochondrial
mRNAs have an almost complete lack of 5- and 3-untrans-
lated nucleotides. The translational start codon is generally
located within three nucleotides of the 5 end of the mRNA (1,
4), a situation very similar to the rare leaderless mRNAs found
in several prokaryotic systems. Recent studies performed with
leaderless mRNAs in bacteria have suggested that IF3 antag-
onizes translation initiation on these mRNAs, at least with
ribosomes containing ribosomal protein S1 and in the presence
of a competing mRNA carrying a Shine/Dalgarno sequence
(56–59). Because mitochondrial ribosomes do not have a pro-
tein equivalent to S1 (60) and have no mRNAs with Shine/
Dalgarno sequences, different constraints may be operating in
the mitochondrial system permitting initiation on mRNAs with
essentially no 5 leader.
Requirement for Other Initiation Factor(s) in Mammalian
Mitochondrial Initiation—Prokaryotic translational initiation
requires IF1 in addition to IF2 and IF3. With the current work,
two of these factors, IF2mt and IF3mt, have been identified in
mammalian mitochondria. Extensive searches of the human
and mouse EST data bases and of the genomes of S. cerevisiae,
D. melanogaster, and C. elegans have failed to provide evidence
for the presence of a factor equivalent to IF1 in mitochondria.
This small protein presents a considerable challenge to identify
in such searches because of its small size (about 70 amino
acids) and low degree of sequence conservation. Biochemical
tests have also failed to date to identify a factor equivalent to
IF1 in mammalian mitochondrial extracts. However, such a
protein would only be present in trace amounts making its
detection a challenge.
To help assess the possible need for a factor equivalent to IF1
in the mitochondrial system, the effect of E. coli IF1 on initia-
tion complex formation was examined using both E. coli and
mitochondrial 55 S ribosomes as well as with E. coli and mito-
chondrial IF2 and IF3. As indicated in Fig. 7A, the presence of
E. coli IF1 has essentially no effect on initiation complex for-
mation on 55 S ribosomes in the presence of IF3mt and IF2mt.
The observation suggests that the mitochondrial system may
not require a factor directly equivalent to IF1.
Further insight into the question of an interaction between
E. coli IF1 and the mitochondrial initiation factors was ob-
tained by examining the effects of this factor on initiation
complex formation on 70 S ribosomes. As a control, the previ-
ously reported stimulation of E. coli IF2 by IF1 was examined,
and a substantial stimulation of fMet-tRNA binding was ob-
served (Fig. 7B). In contrast to the stimulation of E. coli IF2 by
IF1, no stimulation of the activity of IF2mt on 70 S ribosomes
was observed under identical conditions (Fig. 7C). IF2mt alone
actually stimulates initiation complex formation on 70 S ribo-
somes as effectively as E. coli IF2 in the presence of IF1.
The activity of E. coli IF3, like that of IF2, is stimulated by
IF1 (data not shown). However, E. coli IF1 again fails to stim-
ulate the activity of IF3mt on 70 S ribosomes in the presence of
saturating levels of IF2mt (Fig. 7D). Taken together, these
results suggest that IF2mt and IF3mt function efficiently in
initiation complex formation in the absence of IF1. These result
suggest that the conformational change caused by the binding
of IF1 to 30 S subunits (23) can also be generated by the
binding of these mitochondrial initiation factors to 30 S
subunits.
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